A new method that prevents the loss of silencing activity of double-strand RNA in humans
Since the discovery that short double-strand RNA molecules (siRNAs) can trigger sequence-specific degradation of target RNA in cells, great efforts are going on throughout the world to use siRNAs in human therapy.
The group of Dr. Dr. Albrecht Piiper at the Saarland University discovered a way to defend double-stranded and partial double-stranded molecules of RNA – particularly siRNAs – from degradation by RNAse in mammalian body fluid including humans.
Further Information: PDF
Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/9386340
Contact
Dipl.-Kfm. Axel Koch MBA
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Webb captures top of iconic horsehead nebula in unprecedented detail
NASA’s James Webb Space Telescope has captured the sharpest infrared images to date of a zoomed-in portion of one of the most distinctive objects in our skies, the Horsehead Nebula….
Cost-effective, high-capacity, and cyclable lithium-ion battery cathodes
Charge-recharge cycling of lithium-superrich iron oxide, a cost-effective and high-capacity cathode for new-generation lithium-ion batteries, can be greatly improved by doping with readily available mineral elements. The energy capacity and…
Novel genetic plant regeneration approach
…without the application of phytohormones. Researchers develop a novel plant regeneration approach by modulating the expression of genes that control plant cell differentiation. For ages now, plants have been the…
